Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
168.50    0.00 (0.00%)
Bid:
167.50
Ask:
169.00
Spread: 1.50 (0.896%)
Market Cap: £32.90m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

Further Update on Strategy and Changes to Board

19 Jul 2022 07:00

RNS Number : 8720S
Palace Capital PLC
19 July 2022
 

19 July 2022

Palace Capital plc

("Palace Capital" or the "Company")

Further Update on Strategy and Changes to the Board

Palace Capital (LSE:PCA), the Main Market property investment company that owns a diversified portfolio of UK commercial real estate in carefully selected locations outside of London, today provides an update on the Company's strategy following the announcement on 4 July 2022.

In its strategy update of 4 July 2022, the Board undertook to reposition the Company as an ESG driven regional office market specialist, reinvesting proceeds from the sale of the industrial portfolio into improving the existing regional office portfolio and also into new opportunities in the regional office market. In light of shareholder feedback following that update, it has been decided by the Board that such a strategy needs amending. The Board will therefore now focus on maximising cash returns to shareholders, whilst continuing to remain mindful of consolidation in the Real Estate sector as part of its considerations.

The Board will continue to pursue a sale of the Company's industrial portfolio of eight assets, which were independently valued as at 31 March 2022 at £46.5 million. Should a sale of the industrial portfolio be successful it is intended that the net proceeds of the sale, after repayment of debt relating to the industrial portfolio, will be distributed to shareholders by either a special dividend or buyback via a tender offer.

The Board will also continue its strategy of disposing of other non-core investments and seek to complete the remaining sales of the residential apartments at York. Funds from these disposals will be aggregated with those from the sale of the industrial portfolio and distributed to shareholders.

The share buyback programme to repurchase up to 2.3m ordinary shares, representing approximately 5% of the Company's ordinary shares, announced on 4 July 2022 was completed on 11 July 2022 at an average price of 260 pence which represents a 33% discount to the last reported EPRA NTA per share.

In light of the amended strategy, Mickola Wilson (Senior Independent Director), Kim Taylor-Smith (Non-Executive Director), and Paula Dillon (Non-Executive Director) consider that now is the right time to step down from the Board with immediate effect, and therefore will not be offering themselves for re-election at the Annual General Meeting on 29 July 2022. The Company will look to appoint a new Non-Executive Director in due course.

Commenting on today's announcement, Steven Owen, Interim Executive Chairman said: "I would like to thank Mickola, Kim and Paula for their dedication and commitment to Palace Capital, and we wish them all the best for the future."

 

Palace Capital plc Steven Owen, Interim Executive Chairman / Matthew Simpson, Chief Financial OfficerTel. +44 (0)20 3301 8330

Broker NumisHeraclis Economides / Oliver HardyTel: +44 (0)20 7260 1000

Broker Arden Partners plcCorporate Finance: John Llewellyn-Lloyd / Elliot MustoeCorporate Broking: James Reed-DaunterTel: +44 (0)207 614 5900

Financial PR FTI ConsultingDido Laurimore / Giles BarrieTel: +44 (0)20 3727 1000palacecapital@fticonsulting.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDQVLFFLDLBBBB
Date   Source Headline
9th Jun 20261:59 pmRNSHolding(s) in Company
27th May 20264:57 pmRNSHolding(s) in Company
1st May 20261:45 pmRNSTotal Voting Rights
24th Apr 20269:15 amRNSHolding(s) in Company
24th Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Apr 20267:00 amRNSFurther Share Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20263:03 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSShare Buyback Programme
16th Apr 20267:00 amRNSPORTFOLIO VALUATION AS AT 31 MARCH 2026
2nd Apr 20267:00 amRNSHolding(s) in Company
19th Mar 20267:00 amRNSDividend Declaration
4th Mar 20263:02 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSDisposal Update
23rd Jan 20264:30 pmRNSWithdrawal of Meeting Notice and Board Changes
8th Jan 20267:00 amRNSRESPONSE TO LAKESTREET CAPITAL’S ANNOUNCEMENT
5th Jan 202612:15 pmRNSResponse to Lakestreet Capital Partners AG
5th Jan 20267:00 amRNSLAKESTREET DEMANDS CHANGE AT PALACE CAPITAL
4th Dec 20259:01 amRNSHolding(s) in Company
4th Dec 20259:00 amRNSHolding(s) in Company
1st Dec 202512:47 pmRNSHolding(s) in Company
1st Dec 202512:45 pmRNSHolding(s) in Company
27th Nov 20251:32 pmRNSDividend Declaration
27th Nov 20257:00 amRNSInterim Results
5th Nov 202511:18 amRNSHolding(s) in Company
5th Nov 202511:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSHolding(s) in Company
25th Sep 20257:00 amRNSChange of Broker
18th Sep 20257:00 amRNSDividend Declaration
12th Sep 202512:02 pmRNSHolding(s) in Company
10th Sep 202512:07 pmRNSHolding(s) in Company
4th Sep 20251:59 pmRNSHolding(s) in Company
3rd Sep 202511:19 amRNSHolding(s) in Company
3rd Sep 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSResult of Tender Offer
26th Aug 202512:32 pmRNSResult of General Meeting
31st Jul 20257:00 amRNSProposed Tender Offer & Notice of General Meeting
9th Jul 202511:00 amRNSResult of AGM
6th Jun 202511:00 amRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20257:00 amRNSPreliminary Results for year ended 31 March 2025
30th Apr 20257:00 amRNSTRADING AND STRATEGY UPDATE
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.